After another year of zero growth sales of Byetta and continued delays in launching the long-acting formulation there is talk of another 10-15% reduction in staff across the board to keep the profit margins on track for the investors.
All postsUser login
Biotech Jobs
Hot Rumors
Latest Rumors
Biotech News
- AMA Welcomes Big Investment In Medical Training, Australia
- Arcadia Biosciences Completes First Commercial Production Of SONOVA™ 400 High GLA Safflower Oil
- Functional Technologies Develops Yeast Solution For Acrylamide In Processed Foods
- AngioScore Announces Favorable Results From The MASCOT Trial
- Ligand Announces Approval For Revolade(R) In Europe
Amylin needs 23 VPs to drive
Amylin needs 23 VPs to drive it to virtualization: cut back the employee numbers, sweeten the bottom line, and make it look good for a sale. The payouts for the VPs and above will be generous, no doubt.
but what about the 23 vice
but what about the 23 vice presidents?
Post new comment